Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi
de Ascurra Teck, Olga
Schouten, Erik J
Harries, Anthony D
AffiliationClinical HIV Unit, Ministry of Health, Lilongwe, Malawi; The Lighthouse Clinic, Lilongwe, Malawi; Médecins Sans Frontières–Belgium, Malawi Office, Blantyre, Malawi; World Health Organization Country Office, Lilongwe, Malawi; HIV Coordinator, Ministry of Health, Lilongwe, Malawi
MetadataShow full item record
AbstractOBJECTIVE: To describe the supervision, monitoring and evaluation strategies used to assess the delivery of antiretroviral therapy during nationwide scale-up of treatment in Malawi. METHODS: In the first quarter of 2005, the HIV Unit of the Ministry of Health and its partners (the Lighthouse Clinic; Médecins Sans Frontières-Belgium, Thyolo district; and WHO's Country Office) undertook structured supervision and monitoring of all public sector health facilities in Malawi delivering antiretroviral therapy. FINDINGS: Data monitoring showed that by the end of 2004, there were 13,183 patients (5274 (40%) male, 12 527 (95%) adults) who had ever started antiretroviral therapy. Of patients who had ever started, 82% (10 761/13,183) were alive and taking antiretrovirals; 8% (1026/13,183) were dead; 8% (1039/13,183) had been lost to follow up; <1% (106/13,183) had stopped treatment; and 2% (251/13,183) had transferred to another facility. Of those alive and on antiretrovirals, 98% (7098/7258) were ambulatory; 85% (6174/7258) were fit to work; 10% (456/4687) had significant side effects; and, based on pill counts, 96% (6824/7114) had taken their treatment correctly. Mistakes in the registration and monitoring of patients were identified and corrected. Drug stocks were checked, and one potential drug stock-out was averted. As a result of the supervisory visits, by the end of March 2005 recruitment of patients to facilities scheduled to start delivering antiretroviral therapy had increased. CONCLUSION: This report demonstrates the importance of early supervision for sites that are starting to deliver antiretroviral therapy, and it shows the value of combining data collection with supervision. Making regular supervisory and monitoring visits to delivery sites are essential for tracking the national scale-up of delivery of antiretrovirals.
- Malawi's contribution to "3 by 5": achievements and challenges.
- Authors: Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, Mhango E, Aberle-Grasse J, Hochgesang M, Limbambala E, Lungu D
- Issue date: 2007 Feb
- A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006.
- Authors: Lowrance DW, Makombe S, Harries AD, Shiraishi RW, Hochgesang M, Aberle-Grasse J, Libamba E, Schouten E, Ellerbrock T, Kamoto K
- Issue date: 2008 Nov 1
- Early warning indicators for HIV drug resistance in Malawi.
- Authors: Hedt BL, Wadonda-Kabondo N, Makombe S, Harries AD, Schouten EJ, Limbambala E, Hochgesang M, Aberle-Grosse J, Kamoto K
- Issue date: 2008
- A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival.
- Authors: Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Pasulani O, Schouten EJ, Kamoto K, Harries AD
- Issue date: 2007 Nov
- Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries.
- Authors: Harries AD, Zachariah R, Jahn A, Schouten EJ, Kamoto K
- Issue date: 2009 Nov